Condition: Ankylosing Spondylitis
Intervention: Drug: SAR153191 (REGN 88)
Sponsors: Sanofi-Aventis; Regeneron Pharmaceuticals
Active, not recruiting - verified March 2011
By ClinicalTrials.gov 
The independent gateway for the orthopaedic community. Connecting professionals and patients since 1999.